New York bill A07501 adds tianeptine sodium to the list of Schedule II controlled substances.
New York bill A07501 amends the public health law by adding tianeptine sodium to Schedule II of controlled substances. This change subjects tianeptine sodium to stricter regulatory controls, reflecting its potential for abuse and dependence. The bill will take effect 90 days after it becomes law.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.